Contribution: Eureka/Eurostar
Nutrasource Pharmaceutical and Nutraceutical Services Inc.
$259,520.00
EUREKA Project 2020-15143 RESOLCOVID – COVID Related Inflammation - Tracking of SPMs
EF 2020-21 · 2020-12-28
Résumé
EUREKA project 15143 RESOLCOVID with SOLUTEX GC SL (Spain). Nutrasource and Solutex are partnering to research determine which SPMs are the most highly correlated with COVID-19 disease outcome and severity. The most important SPMs will then be developed into a diagnostic device.
Ministère
Programme
Eureka/Eurostar
Emplacement
Guelph|Guelph, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
865125264
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2021-12-31
Agreement Number
962517
Agreement Start Date
2020-12-28
Agreement Title
EUREKA Project 2020-15143 RESOLCOVID – COVID Related Inflammation - Tracking of SPMs
Agreement Title (French)
Projet EUREKA 2020 -15143 RESOLCOVID - Inflammation liée à la COVID - Suivi des SPM
Agreement Type
Contribution
Agreement Value
$259,520.00
Amendment Number
0
Coverage
EUREKA is a leading facilitator of innovation, providing a proven platform for international R&D&I cooperation. | EUREKA est un facilitateur de premier plan en innovation, fournissant une plate-forme reconnu pour la coopération internationale en R & D & I.
Description
EUREKA project 15143 RESOLCOVID with SOLUTEX GC SL (Spain). Nutrasource and Solutex are partnering to research determine which SPMs are the most highly correlated with COVID-19 disease outcome and severity. The most important SPMs will then be developed into a diagnostic device.
Description (French)
Projet EUREKA 15143 RESOLCOVID avec SOLUTEX GC SL (Espagne). Nutrasource et Solutex s'associent pour déterminer quels sont les MSP les plus fortement mis en corrélation avec l'évolution et la gravité de la COVID-19. Les MSP les plus importants seront ensuite développés pour devenir un dispositif de diagnostic.
Expected Results
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Expected Results (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Federal Riding
Guelph
Federal Riding (French)
Guelph
Federal Riding Number
35032
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Eureka/Eurostar
Program Name (French)
Eureka/Eurostar
Program Purpose
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Program Purpose (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Recipient Business Number
865125264
Recipient City
Guelph|Guelph
Recipient Country
CA
Recipient Legal Name
Nutrasource Pharmaceutical and Nutraceutical Services Inc.
Recipient Operating Name
NDI
Recipient Postal Code
N1G 0B4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q4-962517
